Does Alcohol Consumption during Multidrug-resistant Tuberculosis Treatment Affect Outcome?
Supporting Files
-
6 2014 ; 6-2014
-
Available in CDC Stacks on November 03, 2015, 12:00 AM
File Language:
English
Details
-
Alternative Title:Ann Am Thorac Soc
-
Personal Author:
-
Description:Rationale
India reports the largest number of multidrug-resistant tuberculosis cases in the world; yet, no longitudinal study has assessed factors related to treatment outcomes under programmatic conditions in the public sector.
Objectives
To describe demographic, clinical, and risk characteristics associated with treatment outcomes for all patients with multidrug-resistant tuberculosis registered in the Revised National Tuberculosis Control Programme, Kerala State, India from January 1, 2009 to June 30, 2010.
Methods
Cox regression methods were used to calculate adjusted hazard ratios with 95% confidence intervals (CIs) to assess factors associated with an unsuccessful treatment outcome.
Measurements and Main Results
Of 179 patients with multidrug-resistant tuberculosis registered, 112 (63%) had successful treatment outcomes (77 bacteriologically cured, 35 treatment completed) and 67 (37%) had unsuccessful treatment outcomes (30 died, 26 defaulted, 9 failed treatment, 1 stopped treatment because of drug-related adverse events, and 1 developed extensively drug-resistant tuberculosis). The hazard for unsuccessful outcome was significantly higher among patients who consumed alcohol during treatment (adjusted hazard ratio, 4.3; 95% CI, 1.1–17.6) than those who did not. Persons who consumed alcohol during treatment, on average, missed 18 more intensive-phase doses (95% CI, 13–22) than those who did not. Although many patients had diabetes (33%), were ever smokers (39%), or had low body mass index (47%), these factors were not associated with outcome.
Conclusion
Overall treatment success was greater than global and national averages; however, outcomes among patients consuming alcohol remained poor. Integration of care for multidrug-resistant tuberculosis and alcoholism should be considered to improve treatment adherence and outcomes. -
Keywords:
- multidrug-resistant tuberculosis treatment outcome
- multidrug-resistant tuberculosis
- alcohol
- tuberculosis
- India
- Adult
- Alcohol Drinking
- Antitubercular Agents
- Female
- Follow-Up Studies
- Humans
- Incidence
- India
- Male
- Middle Aged
- Mycobacterium tuberculosis
- Population Surveillance
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sputum
- Survival Rate
- Treatment Outcome
- Tuberculosis, Multidrug-Resistant
-
Source:Ann Am Thorac Soc. 11(5):712-718
-
Pubmed ID:24735096
-
Pubmed Central ID:PMC4631605
-
Document Type:
-
Funding:
-
Volume:11
-
Issue:5
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:325d3884f865c46ca5fd31ab83fa446a65f1bb4a20190f0afa3af90c1a8beb37
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access